According to a new research by researchers from the Vascular Physiopathology Laboratory of the IRCCS Neuromed in Pozzill...
Sistema PJSFC (“Sistema”), a publicly traded diversified Russian holding company, announces it has acquired ...
According to a study funded by the National Institute on Aging (NIA), part of the National Institutes of Health, incorpo...
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to ta...
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines for addictions and drug overdose, ...
Dr. Reddy’s today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets. It...
DUSA Pharmaceuticals, Inc., ("DUSA"), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd announced that DUSA...
Walgreens Boots Alliance, Inc. and Verily has announced that they will collaborate on multiple projects under a broad ag...
USFDA permitted marketing of the Miris Human Milk Analyzer, a new diagnostic test to aid healthcare professionals in mea...
Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...
Purdue Research Foundation’s Foundry Investment Fund has invested a total of $750,000 in three life scie...
In new research IBM team details a first-of-a-kind "fingernail sensor" prototype to help monitor human health. The weara...
Projected returns on investment in research and development (R&D) for the top 12 biopharmaceutical companies have fa...
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biophar...
“We can all take steps to help prevent Alzheimer’s disease or slow its course,” says Dr. Mohamme...
Phoenix Life Sciences International Limited, an international adaptive healthcare solutions company has announced that M...
The Board of Directors of Prometic Life Sciences Inc. has announced that it has named Prof. Simon Best as Interim Chief ...
Biotech Start-up company, Relay Therapeutics has announced the successful completion of a $400 million Series C financin...
